{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T21:13:16Z","timestamp":1761858796256,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.mayocp.2022.06.005","type":"journal-article","created":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T08:39:04Z","timestamp":1659515944000},"page":"1580-1583","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Complement C5 inhibition as a Novel Therapeutic Approach in Severe Pre-eclampsia"],"prefix":"10.1016","volume":"97","author":[{"given":"Andrea","family":"Kattah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Kukla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Go","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Szymanski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl A.","family":"Nath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vesna","family":"Garovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.mayocp.2022.06.005_bib1","doi-asserted-by":"crossref","first-page":"481.e1","DOI":"10.1016\/j.ajog.2008.07.048","article-title":"Diagnosis and management of atypical preeclampsia-eclampsia","volume":"200","author":"Sibai","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.mayocp.2022.06.005_bib2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12882-020-01888-5","article-title":"A\u00a0systematic review of the role of eculizumab in systemic lupus erythematosus-associated thrombotic microangiopathy","volume":"21","author":"Wright","year":"2020","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.mayocp.2022.06.005_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jim.2018.07.006","article-title":"Atypical hemolytic uremic syndrome: review of clinical presentation, diagnosis and management","volume":"461","author":"Sridharan","year":"2018","journal-title":"J\u00a0Immunol Methods"},{"issue":"1","key":"10.1016\/j.mayocp.2022.06.005_bib4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s12882-021-02470-3","article-title":"Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre","volume":"22","author":"Grall","year":"2021","journal-title":"BMC Nephrol"},{"issue":"9","key":"10.1016\/j.mayocp.2022.06.005_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-228709","article-title":"Eculizumab, a novel potential treatment for acute kidney injury associated with preeclampsia\/HELLP syndrome","volume":"12","author":"Elabd","year":"2019","journal-title":"BMJ Case Rep"},{"issue":"2","key":"10.1016\/j.mayocp.2022.06.005_bib6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.placenta.2012.11.014","article-title":"Eculizumab for the treatment of preeclampsia\/HELLP syndrome","volume":"34","author":"Burwick","year":"2013","journal-title":"Placenta"},{"issue":"6","key":"10.1016\/j.mayocp.2022.06.005_bib7","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/AOG.0000000000003570","article-title":"Pregnancy prolongation after eculizumab use in early-onset preeclampsia","volume":"134","author":"Lu","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.mayocp.2022.06.005_bib8","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/jog.12295","article-title":"Partial HELLP syndrome: maternal, perinatal, subsequent pregnancy and long-term maternal outcomes","volume":"40","author":"Aydin","year":"2014","journal-title":"J\u00a0Obstet Gynaecol Res"},{"issue":"9","key":"10.1016\/j.mayocp.2022.06.005_bib9","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.34067\/KID.0000992021","article-title":"Quantitative alterations in complement alternative pathway and related genetic analysis in severe phenotype preeclampsia","volume":"2","author":"Alrahmani","year":"2021","journal-title":"Kidney360"},{"issue":"11","key":"10.1016\/j.mayocp.2022.06.005_bib10","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1056\/NEJMoa1502950","article-title":"Eculizumab in pregnant patients with paroxysmal nocturnal hemoglobinuria","volume":"373","author":"Kelly","year":"2015","journal-title":"N\u00a0Engl J Med"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619622003603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619622003603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:38:11Z","timestamp":1758418691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619622003603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0025619622003603"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2022.06.005","relation":{},"ISSN":["0025-6196"],"issn-type":[{"type":"print","value":"0025-6196"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement C5 inhibition as a Novel Therapeutic Approach in Severe Pre-eclampsia","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2022.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}